Jairam Palamanda - Concepedia

Concepedia

Author

Jairam Palamanda

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

J Palamanda, J R Palamanda, Jairam Palamanda, Jairam R Palamanda, Jairam R. Palamanda

45

Publications

1.3K

Citations

22

H-Index

52

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Pfizer (United States)Janssen (United States)The University of Texas at Austin GlaxoSmithKline (United States)

JP

About

Jairam Palamanda is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	697
2	Biochemistry	11	12	649
3	Natural Sciences	9	9	529
4	Health Sciences	1	1	11
5	Cell Biology	1	1	10

Jairam Palamanda

×

31

Publications

1.3K

Citations

22

H-Index

	Year	Citations
Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity Samuel Chackalamannil, Yuguang Wang, William J. Greenlee, Journal of Medicinal Chemistry ImmunologyCardiovascular PharmacologyPharmacotherapyNatural Product HimbacineThrombosis	2008	267
Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione Jairam Palamanda, James P. Kehrer Lipids	1993	94
Inhibition of protein carbonyl formation and lipid peroxidation by glutathione in rat liver microsomes Jairam Palamanda, James P. Kehrer Archives of Biochemistry and Biophysics Rat Liver MicrosomesProtein Carbonyl FormationBiochemistryMedicineLiver Physiology	1992	74
Evaluation of Cynomolgus Monkeys for the Identification of Endogenous Biomarkers for Hepatic Transporter Inhibition and as a Translatable Model to Predict Pharmacokinetic Interactions with Statins in Humans Xiaoyan Chu, Shian‐Jiun Shih, Rachel Shaw, Drug Metabolism and Disposition	2015	59
In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters Xiaoyan Chu, Xiaoxin Cai, Donghui Cui, Drug Metabolism and Disposition	2013	57
Enzyme kinetic properties of human recombinant arylamine n-acetyltransferase 2 allotypic variants expressed in Escherichia coli Dean Hickman, Jairam Palamanda, Jashvant D. Unadkat, Biochemical Pharmacology Enzyme Kinetic PropertiesBiochemistryNatural SciencesEnzyme CatalysisProtein Biosynthesis	1995	55
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control Niresh Hariparsad, Diane Ramsden, Jairam Palamanda, Drug Metabolism and Disposition	2017	46
Evaluation of CYP2B6 Induction and Prediction of Clinical Drug–Drug Interactions: Considerations from the IQ Consortium Induction Working Group—An Industry Perspective Odette A. Fahmi, Mohamad Shebley, Jairam Palamanda, Drug Metabolism and Disposition	2016	45
Inhibition of CYP3A4 in a rapid microtiter plate assay using recombinant enzyme and in human liver microsomes using conventional substrates. Amin A. Nomeir, Curtis Ruegg, M Shoemaker, PubMed PharmacotherapyDiscovery Stage96-Well Microtiter PlateMedicinal ChemistryPharmacological Study	2001	44
Metabolism-Based Identification of a Potent Thrombin Receptor Antagonist Martin C. Clasby, Samuel Chackalamannil, Michael Czarniecki, Journal of Medicinal Chemistry Metabolism-based IdentificationPharmacotherapyThrombosisMedicinal ChemistryCompound 4	2006	39

Page 1